Explore more publications!

Press Releases

Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C
Premier League star investigated over liking anti-LGBTQ footage

Premier League star investigated over liking anti-LGBTQ footage

Strengthening understanding of gendered dimensions of climate-related security risks at the centre of OSCE event

Strengthening understanding of gendered dimensions of climate-related security risks at the centre of OSCE event

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
Precious Metals Management Market Size, Share & Trends Analysis Report By Product
EU Defends Schengen as Border Controls Mount Across Bloc

EU Defends Schengen as Border Controls Mount Across Bloc

EU Reach Forty Years of Schengen Agreement

EU Reach Forty Years of Schengen Agreement

European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
Showcasing Operational Excellence: K9 Units from Across BiH Present Skills in Sarajevo

Showcasing Operational Excellence: K9 Units from Across BiH Present Skills in Sarajevo

Coatings And Application Technologies For Robotics Market To Reach $33.95 Billion By 2029 At 10.6% CAGR: TBRC
bonyf AG receives the EU-MDR Certification Class IIa for PerioCream
Ligand Reports First Quarter 2025 Financial Results
Dental Prosthetics Market Size to Grow from USD 9.12 Billion in 2024 to USD 15.88 Billion by 2034, at a 5.7% CAGR
Press Statement by the Global Governance Group (3G) on its Eighteenth Ministerial Meeting on 24 September 2025

Press Statement by the Global Governance Group (3G) on its Eighteenth Ministerial Meeting on 24 September 2025

QOC Exchange Launches QOC Prime, QOC Plus, and QOC Max Apps in Europe
Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
The European Magazine Releases Its Summer 2025 Edition
4BIO Capital co-leads Actithera’s oversubscribed $75.5 million Series A financing
ANNOUNCEMENT OF INITIAL OFFERING AND INTENTION TO FLOAT
Dental Implants Market worth US$18.79 billion by 2030 with 8.4% CAGR | MarketsandMarkets™.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions